UmbREALung - A Retrospective and prospective, observational, real world multi-cohort study of patients with non-small cell lung cancer (NSCLC) initiating approved drugs developed by AZ or as part of an AZ alliance

Trial Identifier: D4191R00060
Sponsor: AstraZeneca
Start Date: December 2024
Primary Completion Date: June 2032
Study Completion Date: June 2032

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
France AIX EN PROVENCE, France, 13100
France AURILLAC, France, 15000
France BLOIS, France, 41016
France Chalon sur Saone, France, 71321
France chambery, France, 73000
France CRETEIL, France, 94000
France DIEPPE, France, 76202
France DINAN, France, 22100
France Le COUDRAY, France, 28630
France MEAUX, France, 77100
France METZ, France, 57000
France MULHOUSE, France, 68100
France NANCY, France, 54100
France NICE, France, 06000
France PERPIGNAN, France, 66000
France ST BRIEUC, France, 22000
France ST ETIENNE, France, 42100
France ST HERBLAIN, France, 44800
France TROYES, France, 10000
France VALENCIENNES, France, 59300
France VILLEURBANNE, France, 69100